Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 439

1.

UV-A1 therapy for nephrogenic systemic fibrosis.

Tran KT, Prather HB, Cockerell CJ, Jacobe H.

Arch Dermatol. 2009 Oct;145(10):1170-4. doi: 10.1001/archdermatol.2009.245.

PMID:
19841406
2.

Estimates of risk, empirical treatment observations, and unexpected laboratory findings reveal the complexity of nephrogenic systemic fibrosis.

High WA.

Arch Dermatol. 2009 Oct;145(10):1178-82. doi: 10.1001/archdermatol.2009.227. No abstract available.

PMID:
19841408
3.

Revisiting nephrogenic systemic fibrosis in 6 kidney transplant recipients: a single-center experience.

Lemy AA, del Marmol V, Kolivras A, High WA, Matos C, Laporte M, Nortier JL.

J Am Acad Dermatol. 2010 Sep;63(3):389-99. doi: 10.1016/j.jaad.2009.10.038. Epub 2010 Jul 8.

PMID:
20619488
4.

Limited effects of UV-A1 phototherapy in 3 patients with nephrogenic systemic fibrosis.

Kreuter A, Gambichler T, Weiner SM, Schieren G.

Arch Dermatol. 2008 Nov;144(11):1527-9. doi: 10.1001/archderm.144.11.1527. No abstract available.

PMID:
19015438
5.

Large sample of nephrogenic systemic fibrosis cases from a single institution.

Lee CU, Wood CM, Hesley GK, Leung N, Bridges MD, Lund JT, Lee PU, Pittelkow MR.

Arch Dermatol. 2009 Oct;145(10):1095-102. doi: 10.1001/archdermatol.2009.232.

PMID:
19841395
6.

Nephrogenic systemic fibrosis following acute kidney injury and exposure to gadolinium.

Bhaskaran A, Kashyap P, Kelly B, Ghera P.

Indian J Med Sci. 2010 Jan;64(1):33-6. doi: 10.4103/0019-5359.92485.

7.

Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?

Boyd AS, Sanyal S, Abraham JL.

J Am Acad Dermatol. 2010 Feb;62(2):337-42. doi: 10.1016/j.jaad.2009.04.010. Epub 2009 Nov 24.

PMID:
19939504
8.

Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposure.

Grobner T, Prischl FC.

Semin Dial. 2008 Mar-Apr;21(2):135-9. doi: 10.1111/j.1525-139X.2007.00406.x. Epub 2008 Jan 23. Review.

PMID:
18226001
9.

Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.

Kay J.

Ann Rheum Dis. 2008 Dec;67 Suppl 3:iii66-9. doi: 10.1136/ard.2008.102475. Review.

PMID:
19022818
10.

Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation.

Panesar M, Banerjee S, Barone GW.

Clin Transplant. 2008 Nov-Dec;22(6):803-8. doi: 10.1111/j.1399-0012.2008.00886.x. Epub 2008 Aug 18.

PMID:
18713261
11.

Nephrogenic systemic fibrosis--a rapidly progressive disabling disease with limited therapeutic options.

Schieren G, Wirtz N, Altmeyer P, Rump LC, Weiner SM, Kreuter A.

J Am Acad Dermatol. 2009 Nov;61(5):868-74. doi: 10.1016/j.jaad.2009.03.040. Review.

PMID:
19836645
12.

Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.

Lim YL, Lee HY, Low SC, Chan LP, Goh NS, Pang SM.

Clin Exp Dermatol. 2007 Jul;32(4):353-8. Epub 2007 Apr 13. Review.

PMID:
17433041
13.

Ten-year experience with nephrogenic systemic fibrosis: case-control analysis of risk factors.

Bahrami S, Raman SS, Sauk S, Salehmoghaddam S, Villablanca JP, Finn JP, Lu DS.

J Comput Assist Tomogr. 2009 Nov-Dec;33(6):819-23. doi: 10.1097/RCT.0b013e31819d68ed.

PMID:
19940643
14.

Spontaneous eruptive keloid-like cutaneous lesions in a renal transplant patient: a form of nephrogenic systemic fibrosis?

Bremmer M, Deng A, Martin DB.

J Dermatolog Treat. 2009;20(1):63-6. doi: 10.1080/09546630802206678.

PMID:
18629675
15.

Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: three case reports and review of literature.

Mathur K, Morris S, Deighan C, Green R, Douglas KW.

J Clin Apher. 2008;23(4):144-50. doi: 10.1002/jca.20170. Review.

PMID:
18633995
16.

Nephrogenic systemic fibrosis: report of an additional case with granulomatous inflammation.

Wilford C, Fine JD, Boyd AS, Sanyal S, Abraham JL, Kantrow SM.

Am J Dermatopathol. 2010 Feb;32(1):71-5. doi: 10.1097/DAD.0b013e3181b0b859.

PMID:
19940755
17.

Gadolinium-associated nephrogenic systemic fibrosis in a 9-year-old boy.

Foss C, Smith JK, Ortiz L, Hanevold C, Davis L.

Pediatr Dermatol. 2009 Sep-Oct;26(5):579-82. doi: 10.1111/j.1525-1470.2008.00802.x.

PMID:
19840315
18.

The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report.

Wiedemeyer K, Kutzner H, Abraham JL, Thakral C, Carlson JA, Tran TA, Hausser I, Hartschuh W.

Am J Dermatopathol. 2009 Oct;31(7):674-81. doi: 10.1097/DAD.0b013e3181a1fb55.

PMID:
19633532
19.

[Nephrogenic systemic fibrosis: a rare disease with grave consequences].

Kielstein JT, Schiffer M.

Internist (Berl). 2010 Jan;51(1):39-44. doi: 10.1007/s00108-009-2408-9. German.

PMID:
20033388
20.

Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis.

Christensen KN, Lee CU, Hanley MM, Leung N, Moyer TP, Pittelkow MR.

J Am Acad Dermatol. 2011 Jan;64(1):91-6. doi: 10.1016/j.jaad.2009.12.044. Epub 2010 Oct 30.

PMID:
21036418
Items per page

Supplemental Content

Write to the Help Desk